Presentation on the topic of cardiovascular disease

Presentation on the topic of cardiovascular disease

Presentation on the topic of cardiovascular disease
Diuretiko (Diuretika) ay nagpapataas ng pag-ihi ng katawan, na nagreresulta sa pagbaba ng presyon ng dugo. Simpleng paliwanag: Ang tuloy-tuloy na pag-ihi ng katawan ay nagdudulot ng pagbaba ng dami ng plasma sa dugo at sa gayon ay mas kaunting likido sa mga ugat — bumababa ang presyon sa mga pader ng ugat.

>>> ПЕРЕЙТИ НА ОФИЦИАЛЬНЫЙ САЙТ <<<





















Разделы:



Cardio Balance of the heart and circulatory diseases

Presentation on the topic of cardiovascular diseaseAng Cardio Balance Kapseln ay isang epektibo at ligtas na paraan para mapanatili ang kalusugan ng puso at pababain ang presyon ng dugo. Dahil sa kanilang natural na sangkap at mataas na bisa, nagiging maaasahang katuwang sila sa paglaban sa mataas na presyon ng dugo at sa pagpapabuti ng kalidad ng buhay. Cardio Balance helps reduce blood fat levels by reducing the production of cholesterol and triglycerides in the body and improving the transportation of fats in the bloodstream.



Как использовать Presentation on the topic of cardiovascular disease

Cardio Balance treats digestive issues by promoting the absorption of nutrients, and it helps in the elimination of toxic wastes. So, you’re unlikely to experience stomach ache as a side effect. Cardio Balance of the heart and circulatory diseases The urgency of the problem of cardiovascular diseases Healing of high blood pressure by Dr. Myasnikov


Мнение эксперта

Nililinis ang mga ugat na kailangang alagaan mula sa deposito at pinananatili ang kinakailangang lakas ng tibok ng puso! Отзывы о Presentation on the topic of cardiovascular disease



Как заказать?

Заполните форму для консультации и заказа Presentation on the topic of cardiovascular disease. Оператор уточнит у вас все детали и мы отправим ваш заказ. Через 3-7 дней вы получите посылку и оплатите её при получении.



Отзывы покупателей


Арина: Isang malawak na pagpipilian ng mga gamot mismo pati na rin ng mga pamamaraan para sa pagbawas ng gamot mula sa mataas na presyon ang nagbibigay-daan sa iyo na pumili ng pinaka-komportableng programa ng paggamot – ang abot-kaya sa gastos, na may minimal na pagpapakita ng mga side effect, at isinasaalang-alang ang ibang kasamang sakit. Kapag matagal ang pag-inom ng tabletas at binabago ng doktor ang gamot, ito ay dahil ang ilang gamot ay may katangian na magdulot ng pagkagumon, na nagreresulta sa kaunting pagbaba ng bisa nito. Bukod dito, hindi lahat ng grupo ng gamot ay angkop para sa mga pasyente sa iba't ibang edad, at may mga limitasyon din sa pagiging compatible nito sa ibang uri ng gamot.


Кира: Medicines for high blood pressure of the latest Generation. Factors of development of cardiovascular diseases. Cardiovascular Disease Inheritance. Causes of heart note of cardiovascular disease. Minsan, dinadagdagan ng doktor ang base na therapy (mga gamot na kailangang inumin araw-araw) ng mga gamot na iniinom kapag may krisis, kapag ang presyon ay sobrang taas at biglang tumaas. At ang dosis ay pinipili rin nang napaka-indibidwal. Kaya imposible na sabihin kung alin ang pinakamahusay na gamot sa presyon, sa bawat kaso ay magkakaroon ng sariling kombinasyon na bagay sa iyo.


Мария: Diuretiko (Diuretika) ay nagpapataas ng pag-ihi ng katawan, na nagreresulta sa pagbaba ng presyon ng dugo. Simpleng paliwanag: Ang tuloy-tuloy na pag-ihi ng katawan ay nagdudulot ng pagbaba ng dami ng plasma sa dugo at sa gayon ay mas kaunting likido sa mga ugat — bumababa ang presyon sa mga pader ng ugat.

ПЕРЕЙТИ НА ОФИЦИАЛЬНЫЙ САЙТ





Admission to a Sanatorium for cardiovascular disease — Cardiovascular describe diseases

The urgency of the problem of cardiovascular diseases

Vitagerpavak and its relevance for cardiac and vascular disease: An analysis of current research resultsThe treatment and prevention of heart and vascular diseases and represents one of the most important challenges of modern medicine. In this context, immunological approaches are gaining increasing interest, in particular, the possible role of vaccines as Vitagerpavak in the influence of risk factors for cardiovascular disease.Vitagerpavak is a vaccine, which was originally developed for the prophylaxis of herpes simplex infections. It contains inactivated virus particles of the Herpes simplex Virus (HSV) and to strengthen the immune response against these pathogens. Recent studies suggest, however, that a chronic infection with HSV and other herpes viruses may be associated with an increased risk for atherosclerotic diseases.Pathophysiological BasesAtherosclerosis, the basis of many cardiovascular diseases, is no longer valid today only as a lipid-induced vascular changes. Inflammatory processes play a Central role in the progression of Plaque formation and in the instability of progression. Herpes viruses, such as HSV‑1 and cytomegalovirus (CMV) can cause various tissues, including the vascular wall, persist, and there is a chronic, subclinical inflammation.This chronic inflammation can exert the following effects:Activation of macrophages and T‑cells in the vascular wall;Increased production of proinflammatory cytokines (e.g., TNF‑α, IL‑6);Impairment of endothelial function;Amplification of the Oxidation of LDL cholesterol.Potential mechanisms of action of VitagerpavakVaccination with Vitagerpavak a specific stimulated immune response against HSV. A possible protective effect against cardiovascular disease could pass through the following mechanisms:Reduction of viral load: An effective immune response can prevent the reactivation and spread of HSV. As a result, the chronic inflammation is attenuated in the vascular wall.Modulation of systemic inflammation: A controlled immune response could affect the balance between pro‑ and anti-inflammatory cytokines positively.Protection of the endothelial cells By the reduction of viral damage to the function of the vascular endothelium could be preserved, which delays the development of atherosclerosis.Previous Research ResultsEpidemiological studies show a correlation between serological Evidence of HSV infection and the Occurrence of coronary heart disease (CHD). In animal models, it could be demonstrated that vaccination against CMV may reduce the development of Atheroskleroseplaquen. Whether these results are directly on Vitagerpavak and HSV-transferable, must be investigated in clinical intervention studies.Conclusions and OutlookThe vaccine Vitagerpavak also could represent his primary anti — viral effect — a new approach to the prevention of heart and vascular diseases. The underlying mechanism is the reduction of a virus-induced chronic inflammation, which contributes to atherosclerosis would be.Currently, randomized, controlled clinical trials that demonstrate the direct cardioprotective effect of Vitagerpavak missing. Further research is necessary to evaluate the efficacy and safety of such a prevention approach. The study of the interactions between viral infections, the immune system, and cardiovascular disease remains a promising field of research.

Healing of high blood pressure by Dr. Myasnikov

Fundamental to the prevention of cardiovascular diseases

Any disease of the circulatory System

The first aid in case of cardiovascular diseases,





Выводы Presentation on the topic of cardiovascular disease

presentation: cardiovascular disease — causes, risk factors, and preventionSlide 1: TitleCardiovascular diseases: A global health challengeSlide 2: IntroductionCardiovascular diseases (CVD) are one of the leading causes of death worldwide. According to the world health organization (WHO), every year approximately 17.9 million deaths, equivalent to approximately 32% of all deaths worldwide.The aim of this presentation:Definition and classification of CVDThe main causes and risk factorsDiagnostic ProceduresPreventive measures and therapeutic approachesSlide 3: Definition and classificationCardiovascular diseases are a group of diseases that affect the heart and blood vessel system.Important Sub-Groups:Coronary heart disease (CHD): narrowing of the coronary arteries by atherosclerosisHeart failure: Decreased contractile capacity of the heartArrhythmias: heart rhythm disordersHigh blood pressure (hypertension): Permanently elevated blood pressure (≥140/90 mmHg)Stroke (apoplexy): circulatory disorder in the brainPeripheral arterial occlusive disease (paod): constriction in the blood vessels of the extremitiesSlide 4: causes and PathomechanismsMain mechanism: atherosclerosis — deposition of lipids, calcium, and fibrous tissue in the vessel wall.Process flow:Endothelial damage (e.g., hypertension, Smoking)Lipid entry into the vessel wallThe formation of a Plaque (vasoconstriction)Possible plaque rupture → thrombus formation → heart attack or strokeOther Causes:Genetic DispositionInflammatory ProcessesAutoimmune reactionsSlide 5: Modifiable and non-modifiable risk factorsModifiable Not modifiableSmoking age (45 J. in men, and from 55 for women)Overweight / obesity (BMI ≥30 kg/m2), Gender (men are more frequently affected)Lack Of Exercise, Family History OfUnbalanced diet (high, high salt and fat content) Genetic factorsHypertension Diabetes mellitus Elevated cholesterol levels (LDL >3.0 mmol/l) Slide 6: DiagnosticsStandard methods for the detection of CVD:ECG (electrocardiogram): recording of the electrical activity of the heartEchocardiography: ultrasound for the assessment of cardiac structure and functionLong‑term ECG / long‑term blood pressure measurement: detection of rhythmic and blood pressure-related changes in 24 hoursExercise ECG (game gears‑Test): testing under physical stressCoronary angiography: x-ray examination of the heart arteries with contrast mediumLaboratory parameters: lipid spectrum, CRP, Troponin (when infarction is suspected)Slide 7: Approaches To TherapyDrug Therapy:Antihypertensives (e.g., ACE inhibitors, beta-blockers)Statins for lowering cholesterolAnticoagulants (for example, acetylsalicylic acid)Diuretics in heart failureInterventional Procedures:PTCA (balloon dilatation with Stent)Bypass SurgeryLifestyle changes:Smoking abstinenceBalanced diet (DASH diet, Mediterranean cost)Regular physical activity (min. 150 Minutes/Week)Weight controlSlide 8: prevention — the key to the reduction of CVDPrimary prevention is more effective and more cost-effective than the treatment of the advanced disease.Recommended Action:Regular health examinations from 35 years of age (early risk detection)Blood pressure and cholesterol controlPromotion of health awareness in schools and in the workplacePolicy measures (e.g. salt reduction in processed foods, tobacco control laws)Slide 9: SummaryCardiovascular diseases represent a serious global health threat.Atherosclerosis is the main pathophysiological mechanism.Many risk factors are modifiable.Early detection and prevention can reduce deaths significantly.A holistic approach (medical, social, political) is necessary.Slide 10: Acknowledgements and questionsMany thanks for your attention!Questions and discussion are welcome.

Нет комментариев. Ваш будет первым!
Посещая этот сайт, вы соглашаетесь с тем, что мы используем файлы cookie.